Human Kallikrein 9 Antibody, R&D Systems™

Kallikrein 9

Monoclonal

LYOPH

Western Blot 1 ug/mL, Immunoprecipitation 25 ug/mL

Q9UKQ9

KLK9

Mouse myeloma cell line NS0-derived recombinant human Kallikrein 9 Asp20-Asn250 Accession # Q9UKQ9

25 μg

Primary

Detects human Kallikrein 9 in direct ELISAs and Western blots. In Western blots, no cross-reactivity with recombinant human (rh) Kallikrein 1, 3, 4, 5, 6, 7, 8, 10, 11, 12, 13, 14, 15, rhKLKB1, rhHGFA, rhFactor VII, rhFactor X, rhFactor XI, or rhThrombin is observed.

Human

Purified

Western Blot, Immunoprecipitation

366721

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

EC 3.4.21, EC 3.4.21.-, EC 3.4.21.4, kallikrein 9, Kallikrein-like protein 3, kallikrein-related peptidase 9, KLK9, KLKL3, KLK-L3, KLK-L3kallikrein-9, MGC50513

Mouse

Protein A or G purified from hybridoma culture supernatant

RUO

284366

Reconstitute at 0.5 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

IgG2b